Stereotaxis Gets FDA Approval for GenesisX Surgical Robotic System

Dow Jones

11/11

By Terell Wright

Stereotaxis received clearance from the Food & Drug Administration for its latest surgical robotic system, GenesisX.

The maker of surgical robots on Monday said the GenesisX builds upon the benefits of robotic magnetic navigation, and will help with minimally invasive endovascular procedures.

The system features a compact design that incorporates magnetic shielding into its structure in place of the shielding otherwise installed in the walls of the operating room.

The GenesisX will use standard power and does not require structural anchoring.

The company has started a limited launch of the product in the U.S. and Europe. It's the second robotic system the company has offered within five years.

Write to Terell Wright at terell.wright@wsj.com

(END) Dow Jones Newswires

November 10, 2025 17:26 ET (22:26 GMT)

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2582863603"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2582863603\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2582863603?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-11 06:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582863603","market":"hk","top_or_hot":-1,"title":"Stereotaxis Gets FDA Approval for GenesisX Surgical Robotic System","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Terell Wright \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Stereotaxis received clearance from the Food &amp; Drug Administration for its latest surgical robotic system, GenesisX. \n</p>\n<p>\n  The maker of surgical robots on Monday said the GenesisX builds upon the benefits of robotic magnetic navigation, and will help with minimally invasive endovascular procedures. \n</p>\n<p>\n  The system features a compact design that incorporates magnetic shielding into its structure in place of the shielding otherwise installed in the walls of the operating room. \n</p>\n<p>\n  The GenesisX will use standard power and does not require structural anchoring. \n</p>\n<p>\n  The company has started a limited launch of the product in the U.S. and Europe. It's the second robotic system the company has offered within five years. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Terell Wright at terell.wright@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 10, 2025 17:26 ET (22:26 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stereotaxis Gets FDA Approval for GenesisX Surgical Robotic System</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStereotaxis Gets FDA Approval for GenesisX Surgical Robotic System\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-11-11 06:26</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Terell Wright \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Stereotaxis received clearance from the Food &amp; Drug Administration for its latest surgical robotic system, GenesisX. \n</p>\n<p>\n  The maker of surgical robots on Monday said the GenesisX builds upon the benefits of robotic magnetic navigation, and will help with minimally invasive endovascular procedures. \n</p>\n<p>\n  The system features a compact design that incorporates magnetic shielding into its structure in place of the shielding otherwise installed in the walls of the operating room. \n</p>\n<p>\n  The GenesisX will use standard power and does not require structural anchoring. \n</p>\n<p>\n  The company has started a limited launch of the product in the U.S. and Europe. It's the second robotic system the company has offered within five years. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Terell Wright at terell.wright@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 10, 2025 17:26 ET (22:26 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"醫療保健設備","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2582863603","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582863603","pubTimestamp":1762813560,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Stereotaxis received clearance from the Food & Drug Administration for its latest surgical robotic system, GenesisX.The maker of surgical robots on Monday said the GenesisX builds upon the benefits of robotic magnetic navigation, and will help with minimally invasive endovascular procedures.The system features a compact design that incorporates magnetic shielding into its structure in place of the shielding otherwise installed in the walls of the operating room.The GenesisX will use standard power and does not require structural anchoring.The company has started a limited launch of the product in the U.S. and Europe. It's the second robotic system the company has offered within five years.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","STXS":"Stereotaxis Ord"},"translate_title":"Stereotaxis GenesisX手术机器人系统获得FDA批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STXS":0.9},"content_text":"By Terell Wright \n\n\n \n\n\n  Stereotaxis received clearance from the Food & Drug Administration for its latest surgical robotic system, GenesisX. \n\n\n  The maker of surgical robots on Monday said the GenesisX builds upon the benefits of robotic magnetic navigation, and will help with minimally invasive endovascular procedures. \n\n\n  The system features a compact design that incorporates magnetic shielding into its structure in place of the shielding otherwise installed in the walls of the operating room. \n\n\n  The GenesisX will use standard power and does not require structural anchoring. \n\n\n  The company has started a limited launch of the product in the U.S. and Europe. It's the second robotic system the company has offered within five years. \n\n\n \n\n\n  Write to Terell Wright at terell.wright@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 10, 2025 17:26 ET (22:26 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}